Ideagen PLC
("Ideagen," "the Company" or the "Group'')
Issue of new shares under the Share Incentive Plan, Director Dealings and Total Voting Rights
Ideagen PLC (AIM: IDEA), a leading supplier of Information Management Software to highly regulated industries, announces that it has allotted a total of 3,320 new ordinary shares of 1 penny each in the capital of the Company ("Ordinary Shares") following the purchase of 3,320 Ordinary Shares in aggregate by a number of employees under the Company's Share Incentive Plan ("SIP").
Application has been made to the London Stock Exchange for the 3,320 new Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will become effective and trading will commence at 8.00 a.m. on 20th December 2021.
After Admission, the total number of Ordinary Shares in issue will be 293,688,269 and the total number of voting rights will therefore be 293,688,269. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.
In addition to the above, each of the executive directors of the Company: Ben Dorks and Emma Hayes have purchased Ordinary Shares within the SIP as part of the automatic re-investment of dividends received on their shares held in the SIP. Ben Dorks has acquired 9 Ordinary Shares and Emma Hayes 1 Ordinary Share. The directors now have the following beneficial interest in the share capital of the Company.
| Executive Director | Previous shareholding | New shareholding | % of issued share capital held |
| Ben Dorks | 2,991,368 | 2,991,377 | 1.02 |
| Emma Hayes | 291,624 | 291,625 | 0.10 |
Alan Carroll, a non-executive director, has also purchased 42 Ordinary Shares at a price of £2.7173 as a result of the automatic reinvestment of the Company's recent dividend by his nominated broker.
Following the above acquisitions, Mr Carroll's beneficial interest has increased to 204,463 shares representing approximately 0.07% of the Company's issued ordinary share capital.
This announcement contains inside information for the purposes of Regulation 11 of the Market Abuse (Amendment) (EU Exit) Regulations 2019/310.
Enquiries:
| Ideagen plc | 01629 699 100 |
| Ben Dorks, Chief Executive Officer | |
| Emma Hayes, Chief Financial Officer
| |
| | |
| finnCap Limited | 020 7220 0500 |
| Henrik Persson/James Thompson (Nomad) | |
| Alice Lane (ECM)
| |
| | |
| Canaccord Genuity Limited (Joint Broker) | 020 7523 8000 |
| Simon Bridges | |
| Richard Andrews
| |
| | |
| Numis (Joint Broker) | 0207 260 1267 |
| Simon Willis | |
| Joshua Hughes | |
| Tejas Padalkar | |
| | |
| FTI Consulting | 020 3727 1000 |
| Jamie Ricketts | ideagen@fticonsulting.com |
| Dwight Burden | |
| Valerija Cymbal | |
About Ideagen plc
Ideagen's software helps companies comply with regulation and manage risk.
Ideagen is a leader in the +$30 billion regulatory and compliance software market, serving highly regulated industries such as life sciences, healthcare, banking and finance and insurance.
More than 7,500 customers use Ideagen's software, including nine of the top 10 UK accounting firms, 7 of the top aerospace and defence companies and 75% of leading pharmaceutical firms.
Ideagen has a diversified customer base including blue chip, global brands such as Heineken, British Airways, BAE, Aggreko, US Navy, Bank of New York and Johnson Matthey, as well as 250 hospitals across the UK and US.
Ideagen is headquartered in the UK, listed on the London Stock Exchange AIM market (Ticker: IDEA.L), and has key hubs in the UK, EU, US, Middle East and South East Asia. For further information please visit www.ideagen.com.
| 1. | Details of the person discharging managerial responsibilities / person closely associated | |||||
| a) | Name | Ben Dorks | ||||
| 2. | Reason for the Notification | |||||
| a) | Position/status | Chief Executive Officer and PDMR | ||||
| b) | Initial notification/Amendment | Initial notification | ||||
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a) | Name | Ideagen plc | ||||
| b) | LEI | 213800KS1MLITOVNYC85 | ||||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
| a) | Description of the Financial instrument, type of instrument | Ordinary Shares of 1p each | ||||
| Identification code | GB00B0CM0C50 | |||||
| b) | Nature of the transaction | Purchase of Ordinary shares into SIP | ||||
| c) | Price(s) and volume(s)
|
| ||||
| d) | Aggregated information: · Aggregated volume · Price | 9 Ordinary shares awarded at 261.5p per share | ||||
| e) | Date of the transaction | 24 November 2021 | ||||
| f) | Place of the transaction |
| ||||
| 1. | Details of the person discharging managerial responsibilities / person closely associated | |||||
| a) | Name | Emma Hayes | ||||
| 2. | Reason for the Notification | |||||
| a) | Position/status | Chief Financial Officer and PDMR | ||||
| b) | Initial notification/Amendment | Initial notification | ||||
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a) | Name | Ideagen plc | ||||
| b) | LEI | 213800KS1MLITOVNYC85 | ||||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
| a) | Description of the Financial instrument, type of instrument | Ordinary Shares of 1p each | ||||
| Identification code | GB00B0CM0C50 | |||||
| b) | Nature of the transaction | Purchase of Ordinary shares into SIP | ||||
| c) | Price(s) and volume(s)
|
| ||||
| d) | Aggregated information: · Aggregated volume · Price | 1 Ordinary share awarded at 261.5p per share | ||||
| e) | Date of the transaction | 24 November 2021 | ||||
| f) | Place of the transaction |
| ||||
| 1. | Details of the person discharging managerial responsibilities / person closely associated | |||||
| a) | Name | Alan Carroll | ||||
| 2. | Reason for the Notification | |||||
| a) | Position/status | Non-executive Director and PDMR | ||||
| b) | Initial notification/Amendment | Initial notification | ||||
| 3. | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
| a) | Name | Ideagen plc | ||||
| b) | LEI | 213800KS1MLITOVNYC85 | ||||
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
| a) | Description of the Financial instrument, type of instrument | Ordinary Shares of 1p each | ||||
| Identification code | GB00B0CM0C50 | |||||
| b) | Nature of the transaction | Purchase of Ordinary shares into SIP | ||||
| c) | Price(s) and volume(s)
|
| ||||
| d) | Aggregated information: · Aggregated volume · Price | 42 Ordinary shares awarded at 271.73p per share | ||||
| e) | Date of the transaction | 13 December 2021 | ||||
| f) | Place of the transaction |
| ||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
